Clinical Trial Update: Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients [NA]

View source ↗

Summary

An ongoing clinical trial is evaluating whether stimulation with a GLP-1 receptor agonist affects smoking consumption in adults with Type 2 diabetes mellitus, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor agonist

Snippet

Sponsor: Shanghai East Hospital | Conditions: Diabetes Mellitus, Type 2, Nicotine Dependence, Cigarettes | NA | Status: ENROLLING_BY_INVITATION